Diabetes, Pre-diabetes
Conditions
Keywords
Drivers, Chinese, Short Message Service, Cellular Phone
Brief summary
The purpose of this study is to prevent the professional drivers from pre-diabetes to diabetes.
Detailed description
Mobile phone use is almost a routine part of society worldwide. All mobile phones can deliver and receive short-messaging service text messages, providing a perfect medium for delivering information and support. Since short-messaging service is little exploited in clinical research or practice in Chinese population, this study examined the effectiveness of one-way messaging which is less expensive and is easier to undertake. We aimed to determine the effectiveness of using SMS to provide pre-diabetes and diabetes information by promoting healthy lifestyle modification and reducing the two-hour post-glucose loading plasma glucose, the risk of acquiring Type 2 Diabetes Mellitus among professional drivers with pre-diabetes.
Interventions
BEHAVIORALShort Message Service (SMS)
A computer-based text message database was created. Messages prompted subjects to get rid of smoking and eating out, to persevere with the quit smoking attempt with the emphasis on the peer pressure on the smoking cessation by the smoking ban in restaurants. They encouraged them to overcome the barriers of healthy eating diet and physical activity with a block of text messages.
Sponsors
Tung Wah Eastern Hospital
The University of Hong Kong
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* identified within the last 3 months with pre-diabetes which is defined as a fasting plasma glucose level of 5.6-6.9 mmol/L or a two-hour level after a 75 grams glucose load of 7.8-11 mmol/L based on the World Health Organization 1998 criteria; * accessible by mobile phone that could receive Chinese text messages.
Exclusion criteria
* a history of diabetes mellitus; * currently on medicines known to alter glucose tolerance; * did not have a mobile phone; * unable to read Chinese characters; * refused to take part in current study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| incidence rate of DM | Follow-up in 12 months | the incidence rate of DM during first year 12-month period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Waist Circumference | Baseline, follow-up in 12 months and 24 months | — |
| Fasting Glucose | Baseline, follow-up in 12 months and 24 months | Fasting plasma glucose and two-hour post-meal loading plasma glucose |
| Body mass index | Baseline, follow-up in 12 months and 24 months | — |
| Lipid profile | Baseline, follow-up in 12 months and 24 months | Total cholesterol, triglycerides, high density lipoprotein cholesterol and low density lipoprotein cholesterol |
| incidence of DM | Follow-up in 24 months | incidence of DM for first two year 24-month period |
| Blood pressure | Baseline, follow-up in 12 months and 24 months | Systolic blood pressure and diastolic blood pressure |
Countries
Hong Kong
Outcome results
None listed